H Gatanaga, T Hayashida, K Tsuchiya, M … - Clinical Infectious Diseases, 2007 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 44 - Related articles - BL Direct - All 5 versions
V Valcour, R Paul, P Kevin - Clinical Infectious Diseases, 2006 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 35 - Related articles - BL Direct - All 4 versions
AA Motsinger, MD Ritchie, RW Shafer, GK … - Pharmacogenetics and Genomics, 2006 - journals.lww.com Page 1. Original article 837 Multilocus genetic interactions and response to efavirenz-
containing regimens: an Adult AIDS Clinical Trials Group study ... Cited by 24 - Related articles - BL Direct - All 6 versions
JN Ablin, Y Shoenfeld, D Buskila - Journal of Autoimmunity, 2006 - Elsevier As the pathogenesis of fibromyalgia continues to raise debate, multiple putative
triggers have been implicated. The current review summarizes the available data
linking fibromyalgia to either infection or vaccination. Multiple ... Cited by 23 - Related articles - All 5 versions
G Arendt, D de Nocker, HJ von Giesen, T … - Expert Opin. Drug Saf., 2007 - informahealthcare.com The non-nucleoside analogue inhibitor of the reverse transcriptase, efavirenz
(EFV), has become commonly used in highly active antiretroviral combination
therapy in the treatment of HIV infection. Although being effective in ... Cited by 21 - Related articles - BL Direct - All 5 versions
EJ Phillips, SA Mallal - Current Opinion in Infectious Diseases, 2008 - journals.lww.com Summary: Differences in HIV acquisition and progression as well as
antiretroviral efficacy and toxicity will continue to provide the basis for
research to define the genetic basis of such diversity. Despite the ... Cited by 19 - Related articles - BL Direct - All 4 versions
SME Vrouenraets, FWNM Wit, J Tongeren, … - Expert Opin. Pharmacother., 2007 - informahealthcare.com Efavirenz is a non-nucleoside reverse transcriptase inhibitor that in most
treatment guidelines is recommended to be taken combined with two nucleoside
analogue reverse transcriptase inhibitors, as a preferred first-line ... Cited by 15 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org LF Lopez-Cortes, R Ruiz-Valderas, J Ruiz- … - Journal of Antimicrobial Chemotherapy, 2006 - Br Soc Antimicrob Chemo Results: Eighty patients met the inclusion criteria. A permanent drug withdrawal
due to AEs occurred in 10 patients, 5 attributable to efavirenz, and 10 patients
were lost to follow-up before the third month. Efavirenz C min levels with ... Cited by 15 - Related articles - BL Direct - All 8 versions
N Sacktor, N Nakasujja, K Robertson, DB … - Nature Clinical Practice Neurology, 2007 - nature.com Ned Sacktor is an Associate Professor of Neurology in the Johns Hopkins
University School of Medicine, Baltimore, MA, USA. He is currently serving as
the Chairman of the Neurology Subcommittee of the United States Adult AIDS ... Cited by 12 - Related articles - BL Direct - All 5 versions
- ►nih.gov RW Price, S Spudich - The Journal of infectious diseases, 2008 - UChicago Press Featured in Newsweek "The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the
Control of Avian and Swine Influenzas Eileen Thacker and Bruce Janke Last ... Cited by 10 - Related articles - BL Direct - All 5 versions
